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Abstract
Background: Fetal movement counting is a method used by the mother to quantify her baby’s movements, and may
prevent adverse pregnancy outcome by a timely evaluation of fetal health when the woman reports decreased fetal
movements. We aimed to assess effects of fetal movement counting on identification of fetal pathology and pregnancy
outcome.
Methodology: In a multicentre, randomized, controlled trial, 1076 pregnant women with singleton pregnancies from an
unselected population were assigned to either perform fetal movement counting from gestational week 28, or to receive
standard antenatal care not including fetal movement counting (controls). Women were recruited from nine Norwegian
hospitals during September 2007 through November 2009. Main outcome was a compound measure of fetal pathology and
adverse pregnancy outcomes. Analysis was performed by intention-to-treat.
Principal Findings: The frequency of the main outcome was equal in the groups; 63 of 433 (11.6%) in the intervention
group, versus 53 of 532 (10.7%) in the control group [RR: 1.1 95% CI 0.7–1.5)]. The growth-restricted fetuses were more often
identified prior to birth in the intervention group than in the control group; 20 of 23 fetuses (87.0%) versus 12 of 20 fetuses
(60.0%), respectively, [RR: 1.5 (95% CI 1.0–2.1)]. In the intervention group two babies (0.4%) had Apgar scores ,4 at
1 minute, versus 12 (2.3%) in the control group [RR: 0.2 (95% CI 0.04–0.7)]. The frequency of consultations for decreased
fetal movement was 71 (13.1%) and 57 (10.7%) in the intervention and control groups, respectively [RR: 1.2 (95% CI 0.9–1.7)].
The frequency of interventions was similar in the groups.
Conclusions: Maternal ability to detect clinically important changes in fetal activity seemed to be improved by fetal
movement counting; there was an increased identification of fetal growth restriction and improved perinatal outcome,
without inducing more consultations or obstetric interventions.
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Introduction
Maternal perception of a gradual diminishment of fetal activity
is a significant marker of a vulnerable fetus and can indicate
chronic fetal compromise [1–5], precede fetal growth restriction,
stillbirth, preterm birth and emergency Caesarean section [6–8].
The most important marker of decreased fetal activity is what
women perceive as decreasing fetal movements [2,9]. Maternal
vigilance of fetal activity and timely reporting to healthcare
providers when experiencing a decrease may prevent perinatal
morbidity and mortality [2,10–12]. However, there is only low
level evidence on how to counsel women so they are empowered to
timely identify and act on decreased fetal movements [3,10].
Fetal movement counting is a means of screening fetal status.
It is developed as a simple, inexpensive and easily accessible
tool to support the mother in monitoring her baby’s well-being
to identify alarming behavior in time to intervene [13,14]. The
fetal movement monitoring methods can be divided roughly
into two understandings [15], formal fetal movement counting
with specified limits for decreased fetal activity, as opposed to
merely raising maternal awareness and vigilance to fetal activity
and the significance of decreased fetal movement. The latter
approach is consistent with national guidelines in the United
Kingdom [16], the US [17] and Norway [18]. Fetal movement
counting can be promoted as both, as counting per se may
serve as an organized daily effort to ensure vigilance to fetal
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movements, and thus, improve the ongoing maternal self-
screening [19].
There is a lack of evidence of the sensitivity and specificity for
the variety of quantitative definitions of decreased fetal movement
that has been proposed over the years and there is no conclusive
evidence that any of them reduce perinatal morbidity and
mortality [2,3,13,14,20]. Formal fetal movement counting is
disputed among health professionals [16,18,21–23]. Critiques
argue that fetal movement counting may cause psychological
distress [20–22] and induce superfluous consultations and obstetric
interventions (induction of labor, Caesarean section) [20].
However, we have recently demonstrated in our trial that fetal
movement counting is reassuring to mothers, and leads to lower
levels of concern [24]. We aimed to assess the effects of increased
awareness towards fetal activity by use of a fetal movement
counting chart on antenatal identification of fetal pathology,
pregnancy outcomes and the frequency of interventions during
delivery.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Ethics Statement
Ethical approval was obtained from The Regional Committee
for Medical Research Ethics (reference S-07188a) 7 May 2007,
and by The Norwegian Data Inspectorate and Directorate for
Health (reference 07/2504) 19 July 2007. The study was registered
in www.clinicaltrials.gov protocol registration system (number
NCT00513942).
Trial design, setting and subjects
In a randomized, controlled trial pregnant women were
allocated to one of two groups, the intervention group who were
instructed to perform fetal movement counting from gestational
week 28, and the control group who received standard antenatal
care according to the Norwegian guidelines. In Norway, antenatal
care is a public health care service free of charge to which almost
all pregnant women adhere. Participants were approached during
their regular ultrasound screening in pregnancy weeks 17–19
(flow-chart in figure 1). The recruitment brochure provided
information about the purpose of the study: to improve our
knowledge about the effects of fetal movement counting on
expectant mothers. Eligible women were Norwegian-speaking
women with singleton pregnancies; excluding pregnancies where
severe anomalies or other causes for considering termination of the
pregnancy were identified. Women were recruited from Septem-
ber 2007 through November 2009 at nine Norwegian hospitals
from both urban and rural populations, handling total of 8200
births annually.
The current study was a part of a more comprehensive
evaluation of fetal movement counting. The two other studies
required a completed questionnaire in pregnancy week 22 for
participants to be eligible for allocation [24,25]. Thirty six women
(3.4%) were lost to follow up due to delivery at a different hospital
than where they were recruited (figure 2). Among these, there was
one stillbirth caused by a lethal malformation.
Demographic and obstetric information was obtained from case
notes received from the hospitals after the delivery. Registration of
these data was blinded for allocation. Data on maternal age,
parity, marital status and smoking habits in the total population of
women who gave birth were obtained from the Medical Birth
Registry of Norway [26]. The study sample was representative for
the total population of pregnant women in Norway with respect to
parity and the proportion of women of age $35 years, but there
was a lower proportion of smoking women in the study sample
than in the total population (data not shown).
Randomization
Simple randomization was determined according to a comput-
er-generated random allocation list with an equal probability of
ending up in each of the groups. The allocation sequence was
concealed until participants were assigned to trial groups. After
allocation, blinding for group assignment was not desirable neither
for the participants nor their care providers, as use of a fetal
movement counting chart was intended to be an active tool for
interaction between the woman and her midwife or physician.
The intervention
Women in the intervention group received an information
brochure, including instructions on how to use a fetal movement
chart, and were asked to count fetal movements daily from
gestational week 28. A modified Count-to-ten method [27] (figure 3),
previously tested in a Norwegian population [11,12,28] was used.
Further assessment of the methods for fetal movement counting
has been presented elsewhere [3,15,29]. A midwife or an
obstetrician from the participating hospitals or the research study
group called women in the intervention group within two weeks
after counting-start to support them in the interpretation of the
counting method. Women were informed that their subjective
assessment of a significant and sustained reduction in normal fetal
activity for the baby was the primary marker of decreased fetal
activity, i.e. their perception of a change – taking priority over any
formal alarm limits for decreased fetal activity.
Instruments and measures
Primary outcome was a compound measure of the following: (i)
fetal growth restriction ,2.5th centile; (ii): emergency Caesarean
section on fetal indication; (iii) oligohydramnios (as defined by the
clinicians); (iv) pathological blood flow in arteria umbilicalis; (v)
maternal perception of absent fetal movements for more than
24 hours before admission to hospital, or (vi) perinatal death.
Secondary outcomes were (i) Apgar scores ,4 at 1 and 5 minutes;
(ii) fetal growth restriction ,2.5th centile unidentified prior to
birth; (iii) the total number of consultations for decreased fetal
activity; (iv) use of health resources in evaluation of these
pregnancies, and (v) interventions prior to or during delivery.
Fetal growth restriction was defined as a birth weight ,2.5th
centile adjusted for maternal height and weight in early
pregnancy, and baby’s sex [30,31], or an antenatal ultrasound
measure estimating fetal growth,2.5th percentile birth weight (i.e.
,21.5% negative deviation), or a negative trend on serial
antenatal ultrasounds.
Maternal characteristics included demographic information and
risk factors according to Norwegian Guidelines [32], including: (i)
general information: age, educational level, marital status, Body Mass
Index, nicotine and alcohol consumption, and country of origin;
(ii) obstetric risk factors: previous pregnancy with fetal growth
restriction, stillbirth .21 weeks of gestation, preterm delivery,
serious preeclampsia or malformations; (iii) pre pregnancy risk factors:
hypertension, chronic renal or coronary disease, known diabetes
type I or II, inflammatory and rheumatoid diseases, coagulopathy,
epilepsy or hypothyreosis, and (iv) maternal complications identified
during pregnancy: hypertension, preeclampsia, preterm contractions,
prolonged preterm rupture of membranes, haemorrhage .27
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Figure 1. Flow chart data collection.
doi:10.1371/journal.pone.0028482.g001
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weeks of pregnancy, diabetes (any type), urinary tract infection or
other relevant infections.
As an indicator of the user-friendliness of the counting chart,
compliance was measured. A total of 427 (78.5%) women returned
the chart. Of these, 331 women (77.5%) completed the counting chart
more than 50 per cent of the days during the period and at least two
days each week. Compliance did not vary between any subgroups.
Sample size calculation
Sample size calculation was made using the computer program
PS Power and Sample Sizes [33]. The effect size was estimated by
means with standard deviations (SD) for continuous variables. The
goal was to increase the identification of fetal pathology as a
predictor for need of examination or intervention. This was
measured by rates of identification of risk according to the original
Figure 2. Flow chart study participants.
doi:10.1371/journal.pone.0028482.g002
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Figure 3. The fetal movement counting chart (the first of two pages).
doi:10.1371/journal.pone.0028482.g003
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compound measure. Expected prevalence was 13.5%, estimated
from results in previous studies in our population [34] or the
Medical Birth registry of Norway [26]. Detectable changes were
estimated to be a 10% increase of identification of these risk
pregnancies, which gave an estimated sample of 538 in each arm
of the trial with 80% power and a significance level of 0.05.
Statistical analyses
The data were analyzed using SPSS 17.0 (SPSS Inc., Chicago,
IL) and Episheet [35]. Demographic and clinical characteristics
were summarized by the mean 6 one SD for continuous variables
and as frequency counts (percentages) for categorical variables.
Effect size was analyzed using chi square and Fisher exact tests and
included Relative Risk (RR) with its 95% confidence intervals (CI).
Comparisons of maternal age, parity, marital status and smoking
habits between the study sample and the total population of
women delivering in Norway were performed using chi square
test.
The significance level was set at p = 0.05. All analyses were
performed according to the intention-to-treat principle. Analyses
were performed by the researchers without blinding for group
assignment. This manuscript is in compliance with the CON-
SORT statement for reporting trials [36].
Results
We obtained written informed consent from 1155 women. As
demonstrated in the study profile (figure 2), 1076 women were
included in the analyses. At randomization, no differences were
found between the groups with regard to demographic and clinical
characteristics (table 1).
The frequency of the primary outcome was equal between the
groups; 63 of 433 (11.6%) in the intervention group, versus 53 of
532 (10.7%) in the control group [RR: 1.1 95% CI 0.7–1.5)
(p = 0.652)]. The proportion growth-restricted fetuses was similar
between the groups (table 2), but these fetuses were more often
identified prior to birth in the intervention group than in the
control group; 20 of 23 fetuses (87.0%) versus 12 of 20 fetuses
(60.0%) in the groups, respectively, [RR: 1.5 (95% CI 1.0–2.1)
(p = 0.046)]. There were less adverse outcomes in the intervention
group than in the control group (table 2 and table 3). There were
no fetal deaths.
The frequency of consultations because of maternal concern for
decreased fetal movements did not differ between the groups, 71 of
542 pregnancies (13.1%) in the intervention group, versus 57 of
532 pregnancies (10.7%) in the control group [RR: 1.2 (95% CI
0.9–1.7) (p = 0.228)]. The mean gestational age at the time of
maternal report was similar between the groups: mean gestational
day (SD) was 254 (range 196–295) (SD 27.6) and 258 (range 198–
296) (SD 25.9) in the groups, respectively (p = 0.402). Among the
consultations for decreased fetal movements, more often a fetus
with a ,210% weight estimate was identified in the intervention
versus the control group (Table 3).
There were no statistically significant differences between the
groups regarding the frequency of interventions prior to or during
delivery, neither in the total sample (table 2) nor among women
presenting with decreased fetal activity (table 3). Indication for
induction in the 153 vaginal deliveries did not vary between the
intervention and control groups, with the following proportions in
the groups, respectively: 48.1% vs. 53.3% were induced due to
post-term pregnancy, 36.4% vs. 36.9% were based on fetal
indication and 15.6% vs. 9.5% were based on maternal indication
(p = 0.173).
Discussion
This study has suggested that an intervention involving fetal
movement counting, compared to no intervention, was associated
with improved identification of fetal growth restriction and a
reduction in fetuses with severely low Apgar scores – both known
to be associated with further adverse neonatal and childhood
outcomes [37–40]. Maternal report of decreased fetal movement
did not increase in the intervention group, nor did the frequency of
interventions prior to or during delivery. The main outcome
measure was similar in both groups. However, further delibera-
tions after publishing the original protocol concluded that this
Table 1. Baseline demographic and clinical data, N = 1076.
Maternal characteristics Intervention group, n=544 Control group, n =532
n (%a) n (%a)
Maternal age $35 yrs 98 (18.0) 106 (19.9)
Primiparous 228 (41.9) 248 (46.6)
Maternal obesity (Body Mass Index $30 kg/m2) 68 (12.5) 57 (10.7)
$High school graduate 324 (64.5) 304 (61.8)
Single living 37 (6.8) 31 (5.8)
Daily/occasionally smoking 1st trimester 46 (8.5) 51 (9.6)
Daily/occasionally use of alcohol 1st trimester 36 (7.1) 27 (5.6)
Women of Non-Western origin 25 (4.6) 17 (3.2)
Obstetric risk factorsb 18 (3.3) 14 (2.6)
Pre-pregnancy risk factorsc 41 (7.5) 38 (7.1)
Maternal complications during pregnancyd 133 (24.4) 131 (24.6)
aDenominators vary due to missing values.
bPrevious fetal growth restriction, stillbirth .21 weeks of gestation, preterm delivery, serious preeclampsia or malformations.
cHypertension, chronic renal or coronary disease, known diabetes type I or II, inflammatory and rheumatoid diseases, coagulopathy, epilepsy or hypothyroidism.
dHypertension, preeclampsia, preterm contractions, prolonged preterm rupture of membranes, haemorrhage .27th gestational week, diabetes (any type), urinary tract
infection, systemic infection or other infection.
doi:10.1371/journal.pone.0028482.t001
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compound measure does not reflect the intended primary
outcomes, and is not amenable to meaningful interpretation.
There are several reasons for this. Firstly, there is currently no cure
for fetal growth restriction, and thus no screening can affect the
incidence. Secondly, the clinical decisions underlying emergency
caesarean are ambiguous and can equally be seen as the result of
successful screening as an adverse outcome. Similarly, the
diagnoses of oligohydramnios and pathological blood flow in
arteria umbilicalis are ambiguous for successful screening or
adverse outcome. Finally, maternal behavior associated with
adverse outcomes, is also a proxy for fetal movement counting
and thus part of the intervention under study – not a pregnancy
outcome. Rather would the single parts in the compound measure
indicate the effects of the intervention.
In 1989, Grant et al. [14] conducted a large controlled,
multicentre, cluster randomized trial, comparing formal fetal
movement counting vs. counting only for risk pregnancies in a
total population. Grant et al. did not identify any significant
reduction in the in rates of unexplained stillbirth for women using
a counting chart. Several methodological issues have been
identified that have raised questions about the validity of the
results and conclusions [2,41,42]. However, in spite of these
serious critics, the Grant study has had an exceptionally powerful
effect, and has often been cited as evidence against the usefulness
of fetal movement counting [2,16,18,23,42].
Identification of fetal growth restriction
This study was underpowered to detect any difference in perinatal
mortality rates. However, we identified improved identification of fetal
growth restriction, which is the most frequently reported association to
decreased fetal activity and adverse outcomes [6,7,20,43]. Identifica-
tion of fetal growth restriction is of great importance; as growth-
restricted fetuses who are undetected antenatally have a higher mortality
than those that are detected prior to delivery [44,45]. The improved
antenatal identification of growth-restricted fetuses may have
facilitated improved monitoring and timing of delivery.
Table 2. Fetal pathology, clinical management and neonatal outcomes, N = 1076.
Intervention group Control group
n/N (%) n/N (%) RR (95% CI)a P
FETAL PATHOLOGY
Fetal growth restrictionb 23/543 (4.2) 20/530 (3.8) 1.1 (0.6–2.0) 0.700c
Oligohydramnios 16/544 (2.9) 9/532 (1.7) 1.7 (0.8–3.9) 0.174c
Malformations 1/544 (0.2) 0 - 1.000d
Perinatal death 0/544 (0) 0/532 (0) - -
DELIVERY
Start
Spontaneous start 431/544 (79.2) 418/532 (78.6) 1.0 (1.0–1.1) 0.792c
Induced vaginal delivery 77/544 (14.2) 76/532 (14.3) 1.0 (0.7–1.3) 0.951c
Elective Caesarean section 29/544 (5.3) 34/532 (6.4) 0.8 (0.5–1.4) 0.459c
Emergency Caesarean section 7/544 (1.3) 4/532 (0.8) 1.7 (0.5–5.8) 0.383c
Inductions or interventions on fetal indication 95/544 (17.5) 90/532 (16.9) 1.0 (0.8–1.3) 0.812c
Intra partum interventions after a spontaneous
or induced vaginal delivery
Assisted vaginal delivery 34/508 (6.7) 32/494 (6.5) 1.0 (0.7–1.7) 0.891c
Emergency Caesarean section 36/508 (7.1) 32/494 (6.5) 1.2 (0.7–1.7) 0.702c
NEONATAL OUTCOME
Apgar ,4 at 1 minutes 2/544 (0.4) 12/532 (2.3) 0.2 (0.04–0.7) 0.006d
Apgar ,4 at 5 minutes 0/544 (0) 2/534 (0.4) - 0.244d
Birth weight in grams, mean (SDf) 3637 (517) 3611 (499) 0.425e
Small for gestational age ,2.5th centileg 8/543 (1.5) 11/530 (2.1) 0.7 (0.3–1.8) 0.455c
Small for gestational age ,10th centileg 46/543 (8.5) 46/530 (8.7) 1.0 (0.7–1.4) 0.903c
Gestational age at birth in days, mean (SDf) 280 (10.9) 279 (11.2) 0.321e
Preterm delivery 20/544 (3.7) 24/532 (4.5) 0.8 (0.5–1.5) 0.489c
Transferred to neonatal care unith 33/544 (6.1) 30/532 (5.6) 1.1 (0.7–1.7) 0.765c
Female fetal gender 272/544 (50.0) 275/532 (51.7) 1.0 (0.9–1.1) 0.579c
aRelative risk (95% Confidence Interval).
bA baby with an adjusted birth weight below 2.5th percentile, or one ultrasound measurement ,221.5% (2.5th centile), or at least two ultrasound measurements
showing a negative growth trend from at least 10% to at least 13.5% negative deviation.
cP-values refer to chi square test between the control and intervention groups.
dP-values refer to Fisher test between the control and intervention groups.
eP-values refer to T-test between the control and intervention groups.
fStandard Deviation.
gBirth weight for gestational percentiles, adjusted for maternal height and weight in early pregnancy and baby’s sex.
hAdmission to neonatal care unit due to reasons with association to growth restriction or fetal distress.
doi:10.1371/journal.pone.0028482.t002
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Increased maternal awareness by formal fetal movement
counting
The universal self-screening performed as pregnant women
perceive decreased fetal movements, may be the first identification
of fetal compromise [2,5,6]. In line with our previous studies [11,12],
women in the current study came to the hospital with their concern
about decreased fetal activity earlier in the pregnancy. In spite of not
reaching statistical significance due to small sample size for this
specific purpose, this is an important clinical finding, as unsafe delay
in maternal reporting of decreased fetal activity was reduced.
Empowering pregnant women in this universal self-screening
through a daily routine of monitoring fetal activity may improve
her assessment and timely reporting of decreased fetal movements.
Use of health care resources – examinations and
interventions
The frequency of consultations because of maternal report of
decreased fetal movements in the current study is approximating
previous studies [2,11,46]. There is a concern among health
professionals that fetal movement counting may induce time
consuming and unnecessary investigations [14,21,22]. The current
study has demonstrated that fetal movement counting does not
induce more use of health resources; this is an important finding to
disprove this concern.
Pregnancy outcomes
One of the factors associated with decreased fetal activity is a low
Apgar score [47,48]. The clinical relevance of a low Apgar score is
questioned [49], but regardless of the cause, it indicates fetal
compromise and is as such an unwarranted outcome [50]. It has
been have shown that infants with 1-minute Apgar scores #3 have
an increased risk of later disability compared with infants with
normal scores [38,51]. In our previous quality improvement study we
found a tendency towards lower rates of severe neonatal depression
among pregnancies presenting with decreased fetal movements
[11,12]. This randomized trial adds to this finding by identifying
lower rates of severely low Apgar scores in the intervention arm.
By using a clinically oriented definition of fetal growth
restriction, including significant deviation from normal growth
by serial ultrasound, an intervention that led to large proportions
of pregnant women being examined by serial ultrasound would
provide skewed results inflating detection rates. This was not the
case in this study, as the use of ultrasound was identical in both
arms of the trial. Although the consultation rates were similar
between the groups, we found an improved identification of fetal
growth restriction and perinatal outcome in the intervention
group. Uniform information and systematic monitoring of fetal
activity in this group may have improved the mothers’ ability to
distinguish normal variations in fetal activity from changes
representing risk. Thus, the women contacting the delivery clinics
with their concern for decreased fetal activity in the intervention
group may have been better selected.
Methodological considerations
The strength of this study lies in its experimental design.
Furthermore, the sample size was sufficiently large to permit
Table 3. Consultations for decreased fetal movements, identification of pathology, clinical management and interventions,
n = 127.
Intervention group, n=71 Control group, n =56
n/N (%) n/N (%) RR (95% CI)a Pb
IDENTIFICATION OF PATHOLOGY
Fetal weight estimate ,210% by ultrasound measurement 8/70 (11.4) 1/54 (1.9) 6.2 (0.8–47.9) 0.042
Fetal distress 7/70 (10.0) 5/55 (9.1) 1.1 (0.4–3.3) 0.864
Oligohydramnios 6/70 (8.6) 2/54 (3.7) 2.3 (0.5–11.0) 0.274
Pathological blood flow in arteria umbilicalis 3/70 (4.3) 0 - 0.124
Other pathology 2/70 (2.9) 3/54 (5.6) 0.5 (0.1–3.0) 0.449
RESOURCES USED IN EVALUATION OF THESE PREGNANCIES
Cardiotocography for a non-stress test 66/69 (95.7) 50/55 (90.9) 1.1 (1.0–1.2) 0.285
Ultrasound for measurement of fetal growth, amniotic
fluid or fetal activity
54/69 (78.3) 43/55 (78.2) 1.0 (0.8–1.2) 0.992
Measurement of blood flow in arteria uterina by Doppler 29/66 (43.9) 28/53 (52.8) 0.8 (0.6–1.2) 0.335
ANY FOLLOW-UP AFTER THE CONSULTATIONc 33/67 (49.3) 18/56 (32.1) 1.5 (1.0–2.4) 0.055
Recurrent consultation 18/66 (27.3) 10/56 (17.9) 1.5 (0.8–3.0) 0.218
Admission delivery unit for observation 11/67 (16.4) 5/56 (8.9) 1.8 (0.7–5.0) 0.219
Admission delivery unit for induction 4/67 (6.0) 0 - 0.063
Admission delivery unit for emergency Caesarean section 4/67 (6.0) 3/56 (5.4) 1.1 (0.3–4.8) 0.884
DELIVERY – INTERVENTIONS ON FETAL INDICATIONS
Induced start of delivery 14/71 (19.7) 13/56 (23.2) 0.9 (0.4–1.7) 0.633
Emergency Caesarean section 10/71 (14.1) 6/56 (10.7) 1.3 (0.5–3.4) 0.570
Interventions during delivery on fetal indication 17/71 (23.9) 14/56 (25.0) 1.0 (0.5–1.8) 0.891
aRelative risk (95% Confidence Interval).
bP-values refer to chi square tests between the control and intervention groups, respectively.
cAny follow-up after the consultation; recurrent consultation, admission delivery unit for observation, induction or emergency Caesarean section.
doi:10.1371/journal.pone.0028482.t003
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cautious generalization of the findings, although the primary
outcomes are composed of few cases, and size of the effect must be
interpreted with caution. The sample was representative for the
total population of pregnant women in Norway with respect to
demographic characteristics, although the lower proportions of
smoking women in the study sample may indicate a bias towards
healthier pregnancies. Subgroup analyses were not pre-specified in
the protocol, as the actual groups are too small to have enough
power to proclaim any secure effects. Therefore, subgroup
analyses have not been performed, according to the CONSORT
statement [52].
The population of pregnant Norwegian women is relatively
homogeneous; the women who participated were predominantly
employed, cohabiting, white, and well-educated; a typical Scandi-
navian population. Therefore, generalizations should be limited to
similar populations.
It is impossible to restrict the information about fetal movement
completely to only one part of a population. Pregnant women are
frequent users of social networks, and share their personal
experiences and views [53]. The recruitment brochure informed
that the purpose of the study was to improve our knowledge about
the effect of fetal movement counting, and as simple randomiza-
tion procedure was chosen, friends and neighbors may have been
in different allocation groups. The intervention group received
additional information about fetal activity and how to register and
interpret the fetal movement pattern, but this information may
also have reached the women in the control group. This may have
contributed to an increased awareness about fetal activity in the
total sample, as well as among the health care providers. However,
the aim with this study was to evaluate the effects of increased
awareness to fetal activity by performing a regular and formal fetal
movement counting procedure. Thus, the potential increased
awareness towards fetal activity in the total population during the
study period, does not affect the validity of the results.
Although, all women must have heard about fetal movement
counting in the recruitment process, only 143 (30.2%) reported
that they knew about fetal movement counting when asked
directly in a questionnaire. Of the women who knew about fetal
movement counting, 62 (43.4%) had heard or read about it in the
information brochure, whereas 81 (56.6%) had obtained informa-
tion from the Internet, friends, or their midwife or physician.
However, only one woman in the control group (0.2%) had used a
fetal movement chart, indicating a clear separation between the
groups.
Knowledge about the assignment group could potentially affect
the observation, examination or the intervention of the partici-
pants. However, there was no difference between the intervention
and control groups with regard to the frequency of use of any kind
of observation or examination or follow-up, whether in the total
sample or among the women reporting decreased fetal activity and
such bias thus seems unlikely.
Further research
The overall goal for fetal movement counting is reduced fetal
mortality. As the perinatal mortality rates are as low as 4.4/1000
in our population [26], there is a need for a large, multi-centre,
randomized, controlled trial in a more heterogeneous population
than ours to investigate a broad spectrum of the effects of fetal
movement counting on mortality rates. The potential benefit of
empowering women’s self-screening abilities may be significant in
a wide range of populations.
Regardless of the debate on the effect of fetal movement
counting, in current antenatal care, monitoring fetal activity is
ongoing, largely as an unstructured self-screening procedure,
administered and interpreted by the pregnant women individually
[19,21]. As the maternal perception of decreased fetal activity is
the most important screening tool for fetal compromise [2,9–11],
this screening neither should, nor can be stopped – only improved.
Implementation of fetal movement counting would not introduce
a new screening, but only attempt to improve the value of the
existing maternal self-screening.
Conclusions
Maternal ability to detect clinically important changes in fetal
activity seemed to be improved by fetal movement counting; there
was an increased identification of fetal growth restriction and
improved perinatal outcomes, without inducing either more
frequent consultations at hospitals or increased frequency of
interventions before or during delivery. Further research is needed
to assess the effects of fetal movement counting on hard outcomes
such as stillbirth rates.
Supporting Information
Checklist S1 CONSORT Checklist.
(DOC)
Protocol S1 Trial Protocol.
(DOC)
Acknowledgments
Most of all we want to thank the women who participated in the study. We
also want to express a special gratitude to all the participating hospitals and
their coordinators for collecting the material presented: Toril Krohn
Alvestad, Marianne Dalhaug, Inger-Annlaug Eidem, Janne Enoksen, Tove
Falch, Hanne Bra˚then Hansen, Johanne Hopland, Janne Korshamn,
Turid Langvatn, Reidun Langva, Torhild Magnussen, Marit Mathisen,
Christina Persson, Anette Thomas-Krain, Lise Slettebakk, Sigrid Torbla˚
and Elin Ytterbø.
Author Contributions
Conceived and designed the experiments: ES BSP JFF. Performed the
experiments: ES. Analyzed the data: ES BAW JFF. Contributed reagents/
materials/analysis tools: N/A. Wrote the paper: ES BAW BSP JFF.
References
1. Boehm FH, Gabbe SG (2002) Putting it all together. [Review] [9 refs]. Clinical
Obstetrics & Gynecology 45: 1063–1068.
2. Frøen JF (2004) A kick from within - fetal movement counting and the cancelled
progress in antenatal care. J Perinat Med 32: 13–24.
3. Heazell AE, Frøen JF (2008) Methods of fetal movement counting and the
detection of fetal compromise. J Obstet Gynaecol 28: 147–154.
4. O’Sullivan O, Stephen G, Martindale E, Heazell AE (2009) Predicting poor
perinatal outcome in women who present with decreased fetal movement.
Journal of Obstetrics and Gynecology 29: 705–710.
5. Sinha D, Sharma A, Nallaswamy V, Jayagopal N, Bhatti N (2007) Obstetric
outcome in women complaining of reduced fetal movements. J Obstet Gynaecol
27: 41–43.
6. Olesen AG, Svare JA (2004) Decreased fetal movements: background,
assessment, and clinical management. Acta Obstet Gynecol Scand 83: 818–826.
7. Heazell AE, Sumathi GM, Bhatti NR (2005) What investigation is appropriate
following maternal perception of reduced fetal movements? J Obstet Gynaecol
25: 648–650.
8. Frøen JF, Arnestad M, Frey K, Vege, Saugstad OD, et al. (2001) Risk factors for
sudden intrauterine unexplained death: Epidemiologic characteristics of
singleton cases in Oslo, Norway, 1986–1995. Am J Obstet Gynecol 184:
694–702.
9. Berbey R, Manduley A, Vigil-De Gracia P (2001) Counting fetal movements as a
universal test for fetal wellbeing. International Journal of Gynaecology &
Obstetrics 74: 293–295.
Fetal Movement Counting and Perinatal Outcomes
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28482
10. Frøen JF, Tveit JV, Saastad E, Børdahl PE, Stray-Pedersen B, et al. (2008)
Management of decreased fetal movements. Semin Perinatol 32: 307–311.
11. Tveit JVH, Saastad E, Stray-Pedersen B, Børdahl PE, Flenady V, et al. (2009)
Reduction of late stillbirth with the introduction of fetal movement information
and guidelines - a clinical quality improvement. http://www.biomedcentral.
com1471-2393/9/32 Accessed 2010 Jan 12.
12. Tveit JVH, Saastad E, Stray-Pedersen B, Børdahl P, Flenady V, et al. (2010)
Correction: Reduction of late stillbirth with the introduction of fetal movement
information and guidelines - a clinical quality improvement. http://www.
biomedcentral.com/1471-2393/10/49 Accessed 2010 Oct 30.
13. Velazquez MD, Rayburn WF (2002) Antenatal evaluation of the fetus using fetal
movement monitoring. Clin Obstet Gynecol 45: 993–1004.
14. Grant A, Valentin L, Elbourne D, Alexander S (1989) Routine Formal Fetal
Movement Counting and Risk of Antepartum Late Death in Normally Formed
Singletons. Lancet 2: 345–349.
15. Frøen JF, Heazell AE, Tveit JV, Saastad E, Fretts RC, et al. (2008) Fetal
movement assessment. Semin Perinatol 32: 243–246.
16. National Institute for Health and Clinical Excellence (2008) Antenatal care: routine
care for the healthy pregnant women. London, UK: RCOG Press, Available: http://
www.nice.org.uk/nicemedia/pdf/CG62FullGuidelineCorrectedJune2008July2009.
pdf Accessed 2010 July 10.
17. American Academy of Pediatrics, The American College of Obstetricians and
Gynecologists (2007) Guidelines for perinatal care 6th edition. ISBN-
13:9781581102703.
18. Sosial- og Helsedirektoratet (2005) Retningslinjer for svangerskapsomsorgen
[Guidelines for antenatal care]. [Norwegian]. Oslo: Sosial- og Helsedirektoratet.
19. Saastad E, Ahlborg T, Frøen JF (2008) Low maternal awareness of fetal
movement is associated with small for gestational age infants. J Midwifery
Womens Health 53: 345–352.
20. Mangesi L, Hofmeyr GJ (2010) Fetal movement counting for assessment of fetal
wellbeing. Cochrane Database of Systematic Reviews. Issue 1. Art. No.: CD004909.
DOI 10.1002/14651858.
21. Flenady V, MacPhail J, Gardener G, Chadha Y, Mahomed K, et al. (2009)
Detection and management of decreased fetal movements in Australia and New
Zealand: a survey of obstetric practice. Aust N Z J Obstet Gynaecol 49:
358–363.
22. Heazell AE, Green M, Wright C, Flenady V, Frøen JF (2008) Midwives’ and
obstetricians’ knowledge and management of women presenting with decreased
fetal movements. Acta Obstet Gynecol Scand 87: 331–339.
23. Liston R, Sawchuck D, Young D (2007) Fetal Health Surveillance: Antepartum
and Intrapartum Consensus Guideline. J Obst Gynaecol Can 29: 3–56.
24. Saastad E, Winje BA, Israel P, Frøen JF (2011) Fetal movement counting -
maternal concern and experiences. A randomized, controlled trial. Birth. In
press.
25. Saastad E, Israel P, Ahlborg T, Gunnes N, Frøen JF (2011) Fetal movement
counting - effects on maternal-fetal attachment. A multi-center randomized,
controlled trial. Birth 38: 4 December 2011.
26. Medical Birth Registry of Norway (2010) http://mfr-nesstar.uib.no/mfr/
Accessed 2010 Nov 16.
27. Frøen JF, Saastad E, Tveit JV, Børdahl PE, Stray-Pedersen B (2005) [Clinical
practice variation in reduced fetal movements]. Tidsskr Nor Laegeforen 125:
2631–2634.
28. Saastad E, Tveit JVH, Flenady V, Stray-Pedersen B, Fretts R, et al. (2010)
Implementation of uniform information on fetal movement in a Norwegian
population reduces delayed reporting of decreased fetal movement and stillbirth
in primiparous women - a clinical quality improvement. http://www.
biomedcentral.com/1756-0500/3/2 Accessed 2011 Jan 21.
29. Winje BA, Saastad E, Gunnes N, Tveit JVH, Stray-Pedersen B, et al. (2011)
Analysis of ‘‘Count-to-ten’’ fetal movement charts: a prospective cohort study.
BJOG: an International Journal of Obstetrics & Gynaecology 118: 1229–1238.
30. Gjessing HK, Grottum P, Eik-Nes SH (2007) A direct method for ultrasound
prediction of day of delivery: a new, population-based approach. Ultrasound in
Obstetrics & Gynecology 30: 19–27.
31. Eik-Nes SH, Grøttum P, Gjessing HK (2011) eSnurra. http://www.nsfm.no/
esnurra/4.php Accessed 2011 March 15.
32. Norwegian Society for Gynecology and Obstetrics (2008) Veileder i fødselshjelp
2008 (Clinical guidelines for antenatal care, Norwegian only). Oslo.
33. Dupont WD, Plummer WD (2007) PS Power and Sample Size Calculations
available for free on the Internet. http://www.mc.vanderbilt.edu/prevmed/ps/
index.htm, version 2.1.30.
34. Tveit JVH, Saastad E, Stray-Pedersen B, Børdahl P, Frøen JF (2009) Maternal
characteristics and pregnancy outcomes in women presenting with decreased
fetal movements in late pregnancy. Acta Obstetricia et Gynecologica
Scandinavia 88: 1345–1351.
35. Rothman KJ (2011) Episheet - spreadsheets for analysing epidemiologic data.
http://www.epidemiologic.net/studymat/ Accessed 2011 May 20, version.
36. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, et al. (2010)
CONSORT 2010 Explanation and Elaboration: updated guidelines for
reporting parallel group randomised trials. BMJ 340: c869. DOI: 10.1136/
bmj.c869.
37. Jacobsson B, Ahlin K, Francis A, Hagberg G, Hagberg H, et al. (2008) Cerebral
palsy and restricted growth status at birth: population-based case-control study.
BJOG: an International Journal of Obstetrics & Gynaecology 115: 1250–1255.
38. Moster D, Lie RT, Irgens LM, Bjerkedal T, Markestad T (2001) The association
of Apgar score with subsequent death and cerebral palsy: A population-based
study in term infants. J Pediatr 138: 798–803.
39. Lie KK, Groholt EK, Eskild A (2010) Association of cerebral palsy with Apgar
score in low and normal birthweight infants: population based cohort study.
BMJ 341: c4990. DOI:10.1136/bmj.c4990.
40. Clausson B, Gardosi J, Francis A, Cnattingius S (2001) Perinatal outcome in
SGA births defined by customised versus population-based birthweight
standards. Br J Obstet Gynaecol 108: 830–834.
41. Haws RA, Yakoob MYY, Soomro T, Menez EV, Darmstadt GL, et al. (2009)
Reducing stillbirths: screening and monitoring during pregnancy and labour.
BMC Pregnancy and Childbirth 9(Suppl 1): S5. DOI: 10.1186/1471-2393-9-S1-
S5.
42. Withworth MK, Fisher M, Heazell AEP (2011) Reduced Fetal Movements.
http://www.rcog.org.uk/womens-health/clinical-guidance/reduced-fetal-move-
ments-green-top-57 Accessed 2011 April 17.
43. Frøen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B (2004)
Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet
Gynecol Scand 83: 801–807.
44. Ogundipe EM, Wolfe CD, Seed P, Gamsu HR (2000) Does the antenatal
detection of small-for-gestational-age babies influence their two-year outcomes?
Am J Perinatol 17: 73–81.
45. Lindqvist PG, Molin J (2005) Does antenatal identification of small-for-
gestational age fetuses significantly improve their outcome? Ultrasound Obstet
Gynecol 25: 258–264.
46. Sergent F, Lefevre A, Verspyck E, Marpeau L (2005) [Decreased fetal
movements in the third trimester: what to do?]. Gynecol Obstet Fertil 33:
861–869.
47. Yogev Y, Ben-Haroush A, Horowitz ER, Chen R, Hod M, Kaplan B (2003)
PGE2 induction of labor for consistent decreased perception of fetal movements
at term. Int J Gynaecol Obstet 82: 173–178.
48. Ribbert LS, Nicolaides KH, Visser GH (1993) Prediction of fetal acidaemia in
intrauterine growth retardation: comparison of quantified fetal activity with
biophysical profile score. Br J Obstet Gynaecol 100: 653–656.
49. Moster D, Lie RT, Markestad T (2002) Joint association of Apgar scores and
early neonatal symptoms with minor disabilities at school age. Archives of
Disease in Childhood Fetal & Neonatal Edition 86: F16–F21.
50. Thorngren-Jerneck KH (2001) Low 5-minute Apgar score: a population-based
register study of 1 million term births(1). Obstet Gynecol 98: 65–70.
51. Garfinkle J, Shevell MI (2011) Predictors of outcome in term infants with
neonatal seizures subsequent to intrapartum asphyxia. J Child Neurol 26:
453–459.
52. Schulz KF, Altman DG, Moher D, for the CONSORT Group (2010) CONSORT
2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised
Trials. PLoS Med 7: e1000251. DOI: 10.1371/journal.pmed.1000251.
53. Larsson M (2009) A descriptive study of the use of the Internet by women
seeking pregnancy-related information. Midwifery 25: 14–20.
Fetal Movement Counting and Perinatal Outcomes
PLoS ONE | www.plosone.org 10 December 2011 | Volume 6 | Issue 12 | e28482
